Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
The soluble p51 protein in cancer diagnosis, prevention and therapy
Itshak Zusman
*
*
Corresponding author for this work
The Koret School of Veterinary Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The soluble p51 protein in cancer diagnosis, prevention and therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
In Cancer
100%
Cancer Therapy
100%
Tumor Antigen
100%
Cancer Diagnosis
100%
Cancer Prevention
100%
Blood Levels
60%
Cancer Patients
40%
Anticancer Drugs
40%
Cancer Detection
40%
Recurrent Cancer
40%
T Cells
20%
Cancer Types
20%
Tumor Suppression
20%
Chemically Induced
20%
Highly Sensitive
20%
Tumor
20%
Toxic Side Effects
20%
Colon Cancer
20%
Colon
20%
Metastasis
20%
Breast
20%
Melanoma
20%
Correlation Coefficient
20%
Host Immune Response
20%
Preventive Treatment
20%
Cyclophosphamide
20%
Serum Levels
20%
Regression Coefficient
20%
Mammary Gland
20%
Melanoma Growth
20%
B Lymphocytes
20%
Uterus
20%
5-fluorouracil (5-FU)
20%
Rat Mammary Tumors
20%
Skin Glands
20%
Colon Cancer Patients
20%
Colon Glands
20%
Chemotherapy Side Effects
20%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Protein P51
100%
Tumor Antigen
71%
Cancer Recurrence
28%
Melanoma
28%
Colon Carcinoma
28%
Anticarcinogen
28%
Antigen
28%
Rat
28%
Cyclophosphamide
14%
Chemotherapy Regimens
14%
Tamoxifen
14%
Fluorouracil
14%
Side Effect
14%